The phased schedule is intended to push generic drugmakers to move production onshore.

The president said Tuesday he would maintain duty-free treatment for qualifying goods the next two years before hiking the tariffs in ensuing years.

Aseguró que se trata de una medida que busca llevar de regreso la producción farmacéutica al país.

US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to enter the United States duty-free for two years…

Trump has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.

US to impose steep tariffs on generic medicine imports from Aug 2028

The phased schedule is intended to push generic drugmakers to move production onshore.

US President Donald Trump on Wednesday announced steep tariffs on imported generic medicines from August 2028, asserting that the move was aimed at onshoring the manufacturing of…

US President Donald Trump announced a 100% tariff on imported generic pharmaceutical drugs on Tuesday. The tariff, which aims to bolster US pharmaceutical production, is set to go…

Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.

WASHINGTON, July 22 — US President Donald Trump announced yesterday the imposition of steep tariffs on imported generic drugs from August 2028, a move he said was aimed at...

Indian pharma stocks are likely to remain in focus after US President Donald Trump announced a phased tariff plan for generic medicines, offering a two-year tariff exemption…

US President Trump announced a two-year tariff exemption for imported generic medicines, warning of steep 200% duties if production doesn't shift to the US afterward.

La mesure annoncée par le président américain entrera en vigueur à partir d’août 2028, le taux devant ensuite passer à 200 %, un an plus tard. Elle a pour but de forcer les…

(Bloomberg) -- Generic drug manufacturers will have two years to move production to the US or face a 100% import duty from August 2028, President Donald Trump said, threatening…

Indian drugmakers export around $9-10 billion worth of generic medicines to the American market every year. | India News

Trump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufacturing and supply chain strategies. After…

The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one hundred percent, eventually reaching…

President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028, rising to 200% a year later. The move…

Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say the long-term impact may be limited.…

Donald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analysts believe the long-term impact could be…